# AstraZeneca operating income entity: /record/astrazeneca.md predicate: operating_income page: /record/astrazeneca/operating_income as_of: 2026-11-08 cite: AsOf. "AstraZeneca operating income: 13,743,000,000 United States dollar", as of 2025-12-31. Claim clm_763AA2791DE9, https://asof.is/claim/clm_763AA2791DE9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm. As of November 8, 2026, AstraZeneca's operating income on the AsOf record is $13.74 billion, dated December 31, 2025, from a primary source (sec.gov). 11 claims on AstraZeneca's operating income, 1 open and 10 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted. ## Current operating income What the record asserts on 2026-11-08. - [AstraZeneca](/record/astrazeneca.md) | operating_income | 13,743,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_763AA2791DE9](/claim/clm_763AA2791DE9.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm ## Every dated value One claim per line, oldest first. Superseded claims stay visible. - [AstraZeneca](/record/astrazeneca.md) | operating_income | 4,114,000,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_654CC8AE2812](/claim/clm_654CC8AE2812.md) | [clm_9CE71799FE73](/claim/clm_9CE71799FE73.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465918015257/0001104659-18-015257-index.htm - [AstraZeneca](/record/astrazeneca.md) | operating_income | 4,902,000,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_77DE63410430](/claim/clm_77DE63410430.md) | [clm_654CC8AE2812](/claim/clm_654CC8AE2812.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465918015257/0001104659-18-015257-index.htm - [AstraZeneca](/record/astrazeneca.md) | operating_income | 3,677,000,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_0928C69F436C](/claim/clm_0928C69F436C.md) | [clm_77DE63410430](/claim/clm_77DE63410430.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465918015257/0001104659-18-015257-index.htm - [AstraZeneca](/record/astrazeneca.md) | operating_income | 3,387,000,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_CA91157E8FEC](/claim/clm_CA91157E8FEC.md) | [clm_0928C69F436C](/claim/clm_0928C69F436C.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465919012881/0001104659-19-012881-index.htm - [AstraZeneca](/record/astrazeneca.md) | operating_income | 2,924,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_D4ADC56D2F76](/claim/clm_D4ADC56D2F76.md) | [clm_CA91157E8FEC](/claim/clm_CA91157E8FEC.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465920028557/0001104659-20-028557-index.htm - [AstraZeneca](/record/astrazeneca.md) | operating_income | 5,162,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_10DEC07C1593](/claim/clm_10DEC07C1593.md) | [clm_D4ADC56D2F76](/claim/clm_D4ADC56D2F76.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465921022456/0001104659-21-022456-index.htm - [AstraZeneca](/record/astrazeneca.md) | operating_income | 1,056,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_F928384EA602](/claim/clm_F928384EA602.md) | [clm_10DEC07C1593](/claim/clm_10DEC07C1593.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465922025720/0001104659-22-025720-index.htm - [AstraZeneca](/record/astrazeneca.md) | operating_income | 3,757,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_7E98BE75827B](/claim/clm_7E98BE75827B.md) | [clm_F928384EA602](/claim/clm_F928384EA602.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465923023818/0001104659-23-023818-index.htm - [AstraZeneca](/record/astrazeneca.md) | operating_income | 8,193,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_3994638C1B14](/claim/clm_3994638C1B14.md) | [clm_7E98BE75827B](/claim/clm_7E98BE75827B.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465924025553/0001104659-24-025553-index.htm - [AstraZeneca](/record/astrazeneca.md) | operating_income | 10,003,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_763AA2791DE9](/claim/clm_763AA2791DE9.md) | [clm_3994638C1B14](/claim/clm_3994638C1B14.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465925014750/0001104659-25-014750-index.htm - [AstraZeneca](/record/astrazeneca.md) | operating_income | 13,743,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_763AA2791DE9](/claim/clm_763AA2791DE9.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm ## What replaced what - $4.11 billion (2015-12-31 to 2016-12-31, [clm_9CE71799FE73](/claim/clm_9CE71799FE73.md)) was replaced by $4.9 billion from 2016-12-31 ([clm_654CC8AE2812](/claim/clm_654CC8AE2812.md)) - $4.9 billion (2016-12-31 to 2017-12-31, [clm_654CC8AE2812](/claim/clm_654CC8AE2812.md)) was replaced by $3.68 billion from 2017-12-31 ([clm_77DE63410430](/claim/clm_77DE63410430.md)) - $3.68 billion (2017-12-31 to 2018-12-31, [clm_77DE63410430](/claim/clm_77DE63410430.md)) was replaced by $3.39 billion from 2018-12-31 ([clm_0928C69F436C](/claim/clm_0928C69F436C.md)) - $3.39 billion (2018-12-31 to 2019-12-31, [clm_0928C69F436C](/claim/clm_0928C69F436C.md)) was replaced by $2.92 billion from 2019-12-31 ([clm_CA91157E8FEC](/claim/clm_CA91157E8FEC.md)) - $2.92 billion (2019-12-31 to 2020-12-31, [clm_CA91157E8FEC](/claim/clm_CA91157E8FEC.md)) was replaced by $5.16 billion from 2020-12-31 ([clm_D4ADC56D2F76](/claim/clm_D4ADC56D2F76.md)) - $5.16 billion (2020-12-31 to 2021-12-31, [clm_D4ADC56D2F76](/claim/clm_D4ADC56D2F76.md)) was replaced by $1.06 billion from 2021-12-31 ([clm_10DEC07C1593](/claim/clm_10DEC07C1593.md)) - $1.06 billion (2021-12-31 to 2022-12-31, [clm_10DEC07C1593](/claim/clm_10DEC07C1593.md)) was replaced by $3.76 billion from 2022-12-31 ([clm_F928384EA602](/claim/clm_F928384EA602.md)) - $3.76 billion (2022-12-31 to 2023-12-31, [clm_F928384EA602](/claim/clm_F928384EA602.md)) was replaced by $8.19 billion from 2023-12-31 ([clm_7E98BE75827B](/claim/clm_7E98BE75827B.md)) - $8.19 billion (2023-12-31 to 2024-12-31, [clm_7E98BE75827B](/claim/clm_7E98BE75827B.md)) was replaced by $10 billion from 2024-12-31 ([clm_3994638C1B14](/claim/clm_3994638C1B14.md)) - $10 billion (2024-12-31 to 2025-12-31, [clm_3994638C1B14](/claim/clm_3994638C1B14.md)) was replaced by $13.74 billion from 2025-12-31 ([clm_763AA2791DE9](/claim/clm_763AA2791DE9.md)) ## Questions this record answers ### What is AstraZeneca's current operating income? $13.74 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts this claim as of November 8, 2026 (status valid, confidence 0.95). ### When did AstraZeneca's operating income last change? The latest value on the record is $13.74 billion, dated December 31, 2025; before it the record holds $10 billion, dated December 31, 2024 and closed on December 31, 2025. ### What was AstraZeneca's operating income before $13.74 billion? $10 billion, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov). ## Read on - This page: /record/astrazeneca/operating_income (markdown: /record/astrazeneca/operating_income.md) - Entity twin: /record/astrazeneca.md ยท timeline: /timelines/astrazeneca.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.